ConductScience.org, home

Paper41333157

Integrative Multi-Omics and Functional Characterization Reveal MCM4 as a Key Oncogenic Regulator in Hepatocellular Carcinoma.

Qiu M and 1 other. Onco Targets Ther, 2025. Cited by 0 papers, by iCite.

Cite this record

ConductScience Library. Integrative Multi-Omics and Functional Characterization Reveal MCM4 as a Key Oncogenic Regulator in Hepatocellular Carcinoma. Papers, record 41333157. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41333157

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Integrative Multi-Omics and Functional Characterization Reveal MCM4 as a Key Oncogenic Regulator in Hepatocellular Carcinoma.
PubMed
Journal
Onco Targets Ther
PubMed
Year
2025
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
0
iCite
Revised in PubMed
2025-12-05
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Qiu MMin
2Xu LLi

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References39

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
128537669E2F2 induces MCM4, CCNE2 and WHSC1 upregulation in ovarian cancer and predicts poor overall survival.Eur Rev Med Pharmacol Sci2017https://conductscience.org/library/papers/28537669PubMed
239911278Integrative Bioinformatics Analysis for Targeting Hub Genes in Hepatocellular Carcinoma Treatment.Curr Genomics2025https://conductscience.org/library/papers/39911278PubMed
337737200MCM4 expression is associated with high-grade histology, tumor progression and poor prognosis in urothelial carcinoma.Diagn Pathol2023https://conductscience.org/library/papers/37737200PubMed
438499612Multi-omics pan-cancer analyses identify MCM4 as a promising prognostic and diagnostic biomarker.Sci Rep2024https://conductscience.org/library/papers/38499612PubMed
519920109DNA replication licensing factors and aneuploidy are linked to tumor cell cycle state and clinical outcome in penile carcinoma.Clin Cancer Res2009https://conductscience.org/library/papers/19920109PubMed
612714602Identification of MCM4 as a target of the DNA replication block checkpoint system.J Biol Chem2003https://conductscience.org/library/papers/12714602PubMed
735830849Minichromosome Maintenance 4 Is Associated with Cancer Stemness and Poor Survival of Patients with Gastric Cancer.Pathobiology2023https://conductscience.org/library/papers/35830849PubMed
839915447Hepatocellular carcinoma: signaling pathways and therapeutic advances.Signal Transduct Target Ther2025https://conductscience.org/library/papers/39915447PubMed
934172788MCM2-7 complex is a novel druggable target for neuroendocrine prostate cancer.Sci Rep2021https://conductscience.org/library/papers/34172788PubMed
1028125050Links between DNA Replication, Stem Cells and Cancer.Genes (Basel)2017https://conductscience.org/library/papers/28125050PubMed
1135719366Comprehensive Analysis of the Expression and Prognosis for MCM4 in Uterine Corpus Endometrial Carcinoma.Front Genet2022https://conductscience.org/library/papers/35719366PubMed
1237612741Advances in single-cell RNA sequencing and its applications in cancer research.J Hematol Oncol2023https://conductscience.org/library/papers/37612741PubMed
1332822825MCM family in gastrointestinal cancer and other malignancies: From functional characterization to clinical implication.Biochim Biophys Acta Rev Cancer2020https://conductscience.org/library/papers/32822825PubMed
1416133572MCM4 expression in esophageal cancer from southern China and its clinical significance.J Cancer Res Clin Oncol2005https://conductscience.org/library/papers/16133572PubMed
1539709431Lenvatinib and immune-checkpoint inhibitors in hepatocellular carcinoma: mechanistic insights, clinical efficacy, and future perspectives.J Hematol Oncol2024https://conductscience.org/library/papers/39709431PubMed
1639866810The Prognostic Significance of TRs in Hepatocellular Carcinoma: Insights from TCGA and GEO Databases.Biomark Insights2025https://conductscience.org/library/papers/39866810PubMed
1723881943The minichromosome maintenance replicative helicase.Cold Spring Harb Perspect Biol2013https://conductscience.org/library/papers/23881943PubMed
1836303105MCM2 in human cancer: functions, mechanisms, and clinical significance.Mol Med2022https://conductscience.org/library/papers/36303105PubMed
1936882493Differentially expressed discriminative genes and significant meta-hub genes based key genes identification for hepatocellular carcinoma using statistical machine learning.Sci Rep2023https://conductscience.org/library/papers/36882493PubMed
2037198697EZH2 regulates pancreatic cancer cells through E2F1, GLI1, CDK3, and Mcm4.Hereditas2023https://conductscience.org/library/papers/37198697PubMed

See all 39 referencesDownload CSV of references

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
MCM44173PubTator's text mininghttps://conductscience.org/library/genes/4173

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Cited by
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/41333157

GET https://conductscience.org/api/papers/v1/41333157/references?page=2